Sentences with phrase «of pharmacogenomics testing»
Economic Modeling: Our economic modeling core, led by Dr. Ann Wu, uses a variety of modeling approaches to project the medical and financial consequences of genomic medicine, including the use of pharmacogenomic testing to inform medication choices and the use of sequencing as an adjunct to standard newborn screening.
http://www.genomes2people.org/ Not exact matches
«Precision medicine is already positively affecting providers (for example, by reducing ED visits by 30 % through application of molecular profiling treatment strategy); payers ($ 25 billion expected annual spending on genetic tests by 2021, and 45 % of FDA approvals were geared toward targeted therapies in 2013); and pharma (the pharmacogenomics market is expected to be $ 7.5 billion by 2017).»
As such, pharmacogenomic testing becomes fundamental to the development and clinical use of several molecular diagnostics as well as targeted therapies.
This project indicated that not only a vast number of novel potentially functional variants in a total of 231 pharmacogenes was identified but also demonstrated the value of whole - genome sequencing for pharmacogenomic testing by capturing over 18,000 variants per individual in these pharmacogenes.
(2) Treatment research, testing the effectiveness of addiction treatments and their underlying processes, e.g. treatment efficacy, process evaluation, double diagnosis treatmentss, and patient - treatment matching (pharmacogenomics).
Pharmacogenomic testing may help identify subsets of the population who carry genetic variants that may alter psychotropic response to specific antidepressants.
The goal of pre-emptive pharmacogenomics testing is to take into account the impact of each individual's genetic variants when selecting therapy thus providing personalized medicine.
In the meantime, we are working to develop pharmacogenomic tests that can help to optimize the benefit to patients of currently available treatments.»
deCODE plans to use its pharmacogenomic work to develop and market a test that can be used to target the prescription of glucocorticoids to those patients for whom these compounds provide the most effective relief with the least possible side - effects.
Pharmacogenomic tests have the potential to improve resource allocation by improving targeting of treatments so that individuals at risk of having adverse responses to medications or not responding to medications can avoid them, thereby reducing healthcare costs.
Proponents of personalized medicine were thankful for several developments that show this trend is picking up speed: CVS followed Medco's example in expanding pharmacogenomic testing, while biotech and pharma companies, as well as the National Cancer Institute, stepped up their investment in the field.